| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/14/2013 | EP2626346A1 Benzo[k]fluoranthene derivative and organic electroluminescence element containing same |
| 08/14/2013 | EP2625174A1 Co-crystals and salts of ccr3-inhibitors |
| 08/14/2013 | EP2625168A1 Phenyl diamides and a pharmaceutical preparation comprising phenyl diamides |
| 08/14/2013 | EP2624833A1 4- (methylaminophenoxy) pyrdin- 3 - yl - benzamide derivatives for treating cancer |
| 08/14/2013 | CN103249763A Polymer film, phase difference film, polarization plate, liquid crystal display, and compound |
| 08/14/2013 | CN103249721A Arylamide derivatives as TTX-S blockers |
| 08/14/2013 | CN103249720A Oxime compounds as HDL-holesterol raising agents |
| 08/14/2013 | CN103249715A Substituted carbamoylcycloalkyl acetic acid derivatives as NEP inhibitors |
| 08/14/2013 | CN103242371A Aryl-pyridine cyclic Pd-N heterocyclic carbene compound as well as preparation method and application thereof |
| 08/14/2013 | CN103242308A 2-fluoro pyridine derivatives, as well as preparation method and application thereof |
| 08/14/2013 | CN103242228A Method for continuously and controllably preparing small-size pyrithione granules |
| 08/14/2013 | CN103242227A Torasemide compound and pharmaceutical composition thereof |
| 08/14/2013 | CN103242226A Preparation method of medicine intermediate 3-[(3-amino-4-methylaminobenzoyl) (pyridine-2-yl)amino] ethyl propionate |
| 08/14/2013 | CN103242225A Picolinate amino pyridine compound and preparation method thereof |
| 08/14/2013 | CN103242224A Method for extracting and purifying Leucaena leucocephala leaf mimosine |
| 08/14/2013 | CN103242223A Preparation method of 2-pyridineoxydiaryl ketone derivative |
| 08/14/2013 | CN103242222A Preparation method of 3-pyridineacetic acid hydrochloride |
| 08/14/2013 | CN103242192A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 08/14/2013 | CN103242174A Amine-based compound and organic light-emitting diode including the same |
| 08/14/2013 | CN103242167A Amine compound, electrophotographic photoconductor, image forming method, image forming apparatus, and process cartridge |
| 08/14/2013 | CN103242116A Novel method for preparing arylamine through reducing aromatic nitro compound |
| 08/14/2013 | CN102584693B Preparation method for high purity 2-chlorine-3-aminopyridine hydrochloride |
| 08/14/2013 | CN102351788B Method for extracting and refining clopyralid |
| 08/14/2013 | CN102292094B Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical |
| 08/14/2013 | CN102173987B New manchurian walnut bark acid and derivatives thereof, and preparation methods and medical application thereof |
| 08/14/2013 | CN102123988B Squaric acid derivatives as inhibitors of nicotinamide |
| 08/14/2013 | CN101993415B Compound as Hedgehog path inhibitor, medicine composition containing same and application thereof |
| 08/14/2013 | CN101903348B Pyrazole-substituted arylamides |
| 08/14/2013 | CN101687796B Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates |
| 08/14/2013 | CN101331124B Novel vanilloid receptor ligands and their use for producing medicaments |
| 08/13/2013 | US8507688 Process for preparing aryl- and heteroarylacetic acid derivatives |
| 08/13/2013 | US8507671 Insecticidal substituted azinyl derivatives |
| 08/13/2013 | US8507536 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 08/13/2013 | US8507493 Amide and amidine derivatives and uses thereof |
| 08/13/2013 | US8507474 Anthelmintic agents and their use |
| 08/13/2013 | US8506929 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
| 08/13/2013 | CA2613365C Phenoxy acetic acids as ppar delta activators |
| 08/08/2013 | WO2013116075A1 Benzyl sulfonamide derivatives useful as mogat - 2 inhibitors |
| 08/08/2013 | US20130204004 Novel synthesis for thiazolidinedione compounds |
| 08/08/2013 | US20130203987 Ampk-activating heterocyclic compounds and methods for using the same |
| 08/08/2013 | US20130203822 Compounds for treatment of tumors bearing deregulated myc oncoproteins |
| 08/08/2013 | US20130203816 Prolyl hydroxylase inhibitors and methods of use |
| 08/08/2013 | US20130203790 Sulfur-containing compounds as anti-proliferative agents |
| 08/08/2013 | US20130203779 Thioacetate compounds, compositions and methods of use |
| 08/08/2013 | US20130203751 Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof |
| 08/08/2013 | US20130203747 Inhibitors of human immunodeficiency virus replication |
| 08/08/2013 | US20130203727 Napht-2-ylacetic acid derivatives to treat aids |
| 08/08/2013 | US20130203704 Compounds for the treatment of addiction |
| 08/08/2013 | US20130203691 Stable insecticide compositions and methods for producing same |
| 08/08/2013 | US20130202573 Thioacetate compounds, compositions and methods of use |
| 08/07/2013 | EP2623495A1 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate |
| 08/07/2013 | EP2623494A1 Agent for treatment of eye diseases |
| 08/07/2013 | EP2623493A1 N-(hetero)aryl,2-(hetero)aryl-substituted acetamides for use as WNT signaling modulators |
| 08/07/2013 | EP2623492A1 Cyclohexane derivative compound |
| 08/07/2013 | EP2621903A1 N-heteroaryl compounds |
| 08/07/2013 | EP2621899A2 Novel methylcyclohexane derivatives and uses thereof |
| 08/07/2013 | CN103237792A Rare earth metal complex |
| 08/07/2013 | CN103237791A Compositions and methods for the treatment of pathological condition(s) related to GPR35 and/or GPR35-HERG complex |
| 08/07/2013 | CN103237780A Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-cid probe for detecting gene |
| 08/07/2013 | CN103232390A Refining method for high-purity roflumilast |
| 08/07/2013 | CN103232389A Preparation method of 2-chloromethyl-4-methoxyl-3,5-dimethyl pyridine hydrochloride |
| 08/07/2013 | CN103232388A Method for separating 2, 3-dichloropyridine from 2, 3, 6-trichloropyridine |
| 08/07/2013 | CN103232359A Environmental-friendly nitrile hydrolysis method |
| 08/07/2013 | CN103232357A Method for preparing alpha, beta-unsaturated amide |
| 08/07/2013 | CN103232336A Green synthesis method for substituted ketone |
| 08/07/2013 | CN103230389A Novel nitrocatechol derivatives having selectin ligand activity |
| 08/07/2013 | CN102219734B Preparation method for nicotinamide |
| 08/07/2013 | CN102036988B Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof |
| 08/07/2013 | CN101993418B (Methyl) acrylamido carboxylate ionic liquid and preparation method thereof |
| 08/07/2013 | CN101863769B Synthesis method of 2-tetralone derivative |
| 08/07/2013 | CN101838235B 3-phenyl-3'-pyridylallylamine compound and synthesis method thereof |
| 08/07/2013 | CN101711237B Azapeptide derivatives |
| 08/07/2013 | CN101331114B 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors |
| 08/07/2013 | CN101212969B Azinone and diazinone V3 inhibitors for depression and stress disorders |
| 08/07/2013 | CN101190858B Method for catalytic manufacture of aromatic or heteroaromatic nitriles |
| 08/06/2013 | US8501937 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 08/06/2013 | US8501788 Process for recovering flunixin from pharmaceutical compositions |
| 08/06/2013 | US8501784 2-pyridone derivatives as neutrophil elastase inhibitors and their use |
| 08/06/2013 | US8501757 Substituted phenylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | US8501651 Catalyst systems and polymer resins having improved barrier properties |
| 08/06/2013 | CA2629321C Glucagon receptor antagonists, preparation and therapeutic uses |
| 08/06/2013 | CA2586931C Process for preparation of isonicotinic acid derivatives |
| 08/06/2013 | CA2586271C Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 08/06/2013 | CA2563180C Non-nucleoside reverse transcriptase inhibitors |
| 08/06/2013 | CA2532865C Fluoro substituted omega-carboxyaryl diphenyl urea for the inhibition of kinase signaling |
| 08/01/2013 | WO2013112804A1 Formulations of 3-(6-(1-(2.2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 08/01/2013 | WO2013112323A1 Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors |
| 08/01/2013 | WO2013111864A1 Pest control agent |
| 08/01/2013 | WO2013111163A2 Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof |
| 08/01/2013 | WO2013111107A1 Aminopyridine derivatives as plasma kallikrein inhibitors |
| 08/01/2013 | US20130197234 Method for producing optically active amine compound |
| 08/01/2013 | US20130197226 Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complex |
| 08/01/2013 | US20130197225 New Solid Forms of [4-(3-Fluoro-5-Trifluoromethyl-Pyridin-2-Yl)-Piperazin-1-Yl-[5-Methanesulfonyl-2-((S)-2,2,2-Trifluoro-1-Methyl-Ethoxy)-Phenyl]Methanone |
| 08/01/2013 | US20130197059 Integrin antagonist conjugates for targeted delivery to cells expressing lfa-1 |
| 08/01/2013 | US20130197042 Hdac inhibitors |
| 08/01/2013 | US20130197040 Polymorphs of dalfampridine, preparations and uses thereof |
| 08/01/2013 | US20130197039 Novel Benzyl Sulfonamide Derivatives Useful As MOGAT-2 Inhibitors |
| 08/01/2013 | US20130197013 Cyclopropylamine derivatives useful as lsd1 inhibitors |
| 08/01/2013 | US20130196993 N-heteroaryl compounds |